Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum
- DOI
- 10.1001/jamanetworkopen.2025.19919
- Published
- 2025-07-10
- Container
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1001/jamanetworkopen.2025.19919,
title = {Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum},
author = {Diederick M. de Leeuw and Calvin Trieu and Ellen M. Vromen and Elena R. Blujdea and Inge M. W. Verberk and Flora H. Duits and Charlotte E. Teunissen and Yolande A. L. Pijnenburg and Wiesje M. van der Flier and Argonde C. van Harten and Pieter Jelle Visser and Betty M. Tijms},
year = {2025},
journal = {JAMA Network Open},
doi = {10.1001/jamanetworkopen.2025.19919},
url = {https://doi.org/10.1001/jamanetworkopen.2025.19919}
}RIS
TY - JOUR TI - Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum AU - Diederick M. de Leeuw AU - Calvin Trieu AU - Ellen M. Vromen AU - Elena R. Blujdea AU - Inge M. W. Verberk AU - Flora H. Duits AU - Charlotte E. Teunissen AU - Yolande A. L. Pijnenburg AU - Wiesje M. van der Flier AU - Argonde C. van Harten AU - Pieter Jelle Visser AU - Betty M. Tijms PY - 2025 JO - JAMA Network Open DO - 10.1001/jamanetworkopen.2025.19919 UR - https://doi.org/10.1001/jamanetworkopen.2025.19919 ER -
APA
Leeuw, D. M. D., Trieu, C., Vromen, E. M., Blujdea, E. R., Verberk, I. M. W., Duits, F. H., Teunissen, C. E., Pijnenburg, Y. A. L., Flier, W. M. V. D., Harten, A. C. V., Visser, P. J., & Tijms, B. M. (2025). Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.19919
Source records
- crossref · retrieved 2026-09-27T16:37:36.709Z